Evome Medical Technologies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chris Heath
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 1.3yrs |
Board average tenure | 1.6yrs |
Recent management updates
CEO
Chris Heath
less than a year
Tenure
Mr. Christopher Heath, also known as Chris, is Director of Evome Medical Technologies Inc. from March 2025 and serves as Interim Chief Executive Officer. He was Chief Executive Officer of MedBright AI Inve...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Director | no data | no data | no data | |
Principal Accounting Officer & Interim Chief Financial Officer | 1.3yrs | no data | no data | |
Chief Operating Officer | less than a year | no data | no data | |
Vice President of Marketing & Sales | 1.6yrs | no data | no data | |
Director of Human Resources | 1.3yrs | no data | no data | |
Vice President of Capital Markets & Financial Communications | no data | no data | no data | |
Executive Officer | no data | no data | no data |
1.3yrs
Average Tenure
Experienced Management: EVMT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim CEO & Director | less than a year | no data | no data | |
Independent Vice-Chairman | 4.7yrs | CA$40.49k | 0.057% CA$ 237.4 | |
Independent Director | 1.3yrs | no data | no data | |
Non-Executive Vice Chair | 2yrs | CA$282.79k | 0% CA$ 0 |
1.6yrs
Average Tenure
72yo
Average Age
Experienced Board: EVMT's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/08 02:51 |
End of Day Share Price | 2025/05/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Evome Medical Technologies Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Doug Cooper | Beacon Securities Limited |
Greg McLeish | Leede Financial Inc |